WorkspaceResearch
AGPPHARMACEUTICALSAlpha Score••Free accountSep-26

AGP Ltd

Shariah compliant
Last close
Rs150.98
−1.65%
3 monthsAs of 19 Nov
BusinessSlowingGrowthGrew 10%+last yearValueCore planHealthStretchedDividendRising

A dividend raised 4 years running and analysts seeing upside. A stretched balance sheet and the price is in a downtrend.

Working

  • 2 analysts' average target Rs 246.40, 63% above the price.
  • Free cash flow Rs 2.2bn last year, after Rs 597m the year before.
  • Operating margin 27% over the last twelve months, in line with its three-year average.

To watch

  • P/E 11.9 against a sector median of 11.9.
  • Debt is 76% of equity in the latest quarter.
  • Revenue down 15% on the same quarter last year.
Full analysis · free account

Keep reading AGP: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, AGP's sales fell 15% to Rs 6.4bn, from Rs 7.6bn, and profit after tax fell 12% to Rs 1.0bn, from Rs 1.2bn (compared with Jul–Sep 2025).

Earnings per share were Rs 3.05, against Rs 3.72 a year earlier.

At Rs 150.98, AGP trades at 12.7 times earnings, with a dividend yield of 5.3%.

P/E ratio
12.7
Dividend yield
5.3%
Dividend payout
0%
of earnings
Return on equity
24%
Net margin
15.0%
last 12 months
Debt to equity
0.76

AGP quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 6.4bnRs 1.0bn16.0%Rs 3.05—
Apr–Jun 2026Rs 4.7bnRs 586.5mn12.5%Rs 2.15Rs 2.00
Jan–Mar 2026Rs 6.8bnRs 968.0mn14.1%Rs 3.06—
Oct–Dec 2025Rs 8.5bnRs 1.5bn17.2%Rs 4.38Rs 6.00
Jul–Sep 2025Rs 7.6bnRs 1.2bn15.4%Rs 3.72—
Apr–Jun 2025Rs 5.6bnRs 636.0mn11.4%Rs 2.20Rs 2.00
Jan–Mar 2025Rs 7.2bnRs 1.1bn14.8%Rs 3.04—
Oct–Dec 2024Rs 7.4bnRs 1.4bn18.6%Rs 4.27Rs 4.00

AGP annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Dec 2025Rs 28.9bnRs 4.3bnRs 13.34Rs 8.00
Year to Dec 2024Rs 25.0bnRs 3.0bnRs 9.53Rs 4.00
Year to Dec 2023Rs 18.7bnRs 1.8bnRs 5.59Rs 2.50
Year to Dec 2022Rs 14.5bnRs 1.7bnRs 5.61Rs 2.00
Year to Dec 2021Rs 9.3bnRs 1.8bnRs 6.24Rs 2.50

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 34.2bn
Shareholders' equity
Rs 17.2bn
Cash & bank
Rs 400.6mn
Total debt
Rs 13.1bn
Current ratio
0.87
3-month high
Rs 199.53
3-month low
Rs 147.29
1-month change
-5.7%
3-month change
-15.2%

Read more about AGP

Other pharmaceuticals companies

AGP: common questions

What is AGP's share price?

AGP Ltd (AGP) last closed at Rs 150.98 on the Pakistan Stock Exchange.

Does AGP pay a dividend?

Yes. AGP Ltd paid Rs 8.00 per share for the year to Dec 2025, and the stock's dividend yield is 5.3%.

What were AGP's latest results?

In the Jul–Sep 2026 quarter, AGP's sales fell 15% to Rs 6.4bn, from Rs 7.6bn, and profit after tax fell 12% to Rs 1.0bn, from Rs 1.2bn (compared with Jul–Sep 2025).

What is AGP's P/E ratio?

At Rs 150.98, AGP trades at 12.7 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.